This morning prior to the U.S. markets open, genomic medicine company Sangamo Therapeutics Inc. (SGMO:NASDAQ), reported fourth quarter and full-year 2019 financial results and recent business …
More Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration Videos